ACG
CMRAW

Aventail Capital Group’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Aventail Capital Group’s Portfolio CMRAW Stock Details CMRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-75,000
Closed -$4K – 67
2022
Q3 		$4K Hold
75,000
– – ﹤0.01% 51
2022
Q2 		$11K Buy
+75,000
New +$11K ﹤0.01% 39